Several Northeast Ohio Med Spas Get Blasted by Ohio Attorney General

April 17, 2025

Ohio Attorney General Dave Yost announced Wednesday he sent letters to 14 medical spas, many in Northeast Ohio, warning them to stop making false or misleading claims about their versions of popular weight-loss drugs.

With the popularity of FDA approved drugs such as Ozempic, Wegovy, Zepbound and Mounjaro, several health spas are offering compounds of the active ingredient in those drugs to customers.

According to Yost, compound drugs like semaglutide and/or tirzepatide have not been tested and approved by the FDA, and some spas are advertising them as just as safe and effective.

Read more at Cleveland 19 News >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • The Beauty Health Company (SKIN) Rebrands to SkinHealth Systems
    • Amazon Launches GLP-1 Weight Loss Program with One Medical
    • Botox Cosmetic’s “The Confidence Collective” to Empower 250 Women Entrepreneurs
    • Medical Spa Show 2027 Call for Presentations Now Open
    • FDA Warning Letter to Texas Medical Spa Signals Increased Compliance Enforcement